|Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study|
I Cleynen, G Boucher, L Jostins, LP Schumm, S Zeissig, T Ahmad, ...
The Lancet 387 (10014), 156-167, 2016
|Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease|
KM de Lange, L Moutsianas, JC Lee, CA Lamb, Y Luo, NA Kennedy, ...
Nature genetics 49 (2), 256, 2017
|Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics|
NT Ventham, NA Kennedy, ER Nimmo, J Satsangi
Gastroenterology 145 (2), 293-308, 2013
|Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway|
JC Lee, M Espéli, CA Anderson, MA Linterman, JM Pocock, NJ Williams, ...
Cell 155 (1), 57-69, 2013
|The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota composition by 16S rRNA gene sequencing|
NA Kennedy, AW Walker, SH Berry, SH Duncan, FM Farquarson, P Louis, ...
PloS one 9 (2), e88982, 2014
|High-density mapping of the MHC identifies a shared role for HLA-DRB1* 01: 03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis|
P Goyette, G Boucher, D Mallon, E Ellinghaus, L Jostins, H Huang, ...
Nature genetics 47 (2), 172, 2015
|Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway|
ER Nimmo, JG Prendergast, MC Aldhous, NA Kennedy, P Henderson, ...
Inflammatory bowel diseases 18 (5), 889-899, 2011
|MicroRNAs: new players in IBD|
R Kalla, NT Ventham, NA Kennedy, JF Quintana, ER Nimmo, AH Buck, ...
Gut 64 (3), 504-513, 2015
|The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease|
P Henderson, A Casey, SJ Lawrence, NA Kennedy, K Kingstone, ...
The American journal of gastroenterology 107 (6), 941, 2012
|Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease|
J Torres, RK Boyapati, NA Kennedy, E Louis, JF Colombel, J Satsangi
Gastroenterology 149 (7), 1716-1730, 2015
|Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome|
I Trbojević Akmačić, NT Ventham, E Theodoratou, F Vučković, ...
Inflammatory bowel diseases 21 (6), 1237-1247, 2015
|Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7|
Y Luo, KM de Lange, L Jostins, L Moutsianas, J Randall, NA Kennedy, ...
Nature genetics 49 (2), 186, 2017
|The role of glycosylation in IBD|
E Theodoratou, H Campbell, NT Ventham, D Kolarich, M Pučić-Baković, ...
Nature reviews Gastroenterology & hepatology 11 (10), 588, 2014
|Two-stage genome-wide methylation profiling in childhood-onset Crohn's disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci|
AT Adams, NA Kennedy, R Hansen, NT Ventham, KR O'Leary, ...
Inflammatory bowel diseases 20 (10), 1784-1793, 2014
|Dietary manipulation of oncogenic microRNA expression in human rectal mucosa: a randomized trial|
KJ Humphreys, MA Conlon, GP Young, DL Topping, Y Hu, JM Winter, ...
Cancer prevention research 7 (8), 786-795, 2014
|Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease|
NT Ventham, NA Kennedy, AT Adams, R Kalla, S Heath, KR O'leary, ...
Nature communications 7, 13507, 2016
|A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta‐analysis|
NA Kennedy, E Rhatigan, IDR Arnott, CL Noble, AG Shand, J Satsangi, ...
Alimentary pharmacology & therapeutics 38 (10), 1255-1266, 2013
|Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients|
NA Kennedy, R Kalla, B Warner, CJ Gambles, R Musy, S Reynolds, ...
Alimentary pharmacology & therapeutics 40 (11-12), 1313-1323, 2014
|Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial|
C Mowat, I Arnott, A Cahill, M Smith, T Ahmad, S Subramanian, S Travis, ...
The Lancet Gastroenterology & Hepatology 1 (4), 273-282, 2016
|Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16–50 years|
NA Kennedy, A Clark, A Walkden, JCW Chang, F Fascí-Spurio, M Muscat, ...
Journal of Crohn's and Colitis 9 (1), 41-49, 2014